The disruption of hepatic cytochrome P450 reductase alters mouse lipid metabolism

Journal of Proteome Research

Volumn 6, Issue 10, 2007, Pages 3976-3984

  Mutch, David M ^a,f   Klocke, Bernward ^b   Morrison, Peter ^c   Murray, Carol A ^d   Henderson, Colin J ^e   Seifert, Martin ^b   Williamson, Gary ^a  

^a NESTLÉ RESEARCH CENTER   (Switzerland)

^b Genomatix GmbH   (Germany)

^c ROSETTA INPHARMATICS   (United States)

^d CXR Biosciences Ltd   (United Kingdom)

^e UNIVERSITY OF DUNDEE   (United Kingdom)

^f HÔTEL DIEU   (France)

Author keywords

Knock out; Lipidomics; Microarray; Oxidoreductase; Promoter analysis; Systems biology

Indexed keywords

CARBOXYLIC ACID; CELL NUCLEUS RECEPTOR; CHOLESTEROL ESTER; CYTOCHROME P450 REDUCTASE; MONOUNSATURATED FATTY ACID; OXIDOREDUCTASE; PHOSPHATIDYLCHOLINE; STEROL REGULATORY ELEMENT BINDING PROTEIN 1C; TRIACYLGLYCEROL;

ALGORITHM; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BILE ACID METABOLISM; BIOINFORMATICS; CHOLESTEROL METABOLISM; CONTROLLED STUDY; CYTOCHROME P450 OXIDOREDUCTASE DEFICIENCY; ELECTRON TRANSPORT; ENZYME DEFICIENCY; FATTY ACID METABOLISM; FATTY ACID OXIDATION; GENE EXPRESSION; LIPID METABOLISM; LIPID OXIDATION; LIPID TRANSPORT; MALE; MITOCHONDRIAL RESPIRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRANSCRIPTOMICS;

ANIMALS; BILE ACIDS AND SALTS; CHOLESTEROL; FATTY ACIDS; GENE EXPRESSION PROFILING; GLYCERIDES; INTESTINAL MUCOSA; JEJUNUM; LIPID METABOLISM; LIVER; MICE; MICE, INBRED C57BL; MICE, NUDE; NADPH-FERRIHEMOPROTEIN REDUCTASE; ORGAN SPECIFICITY; PHOSPHATIDYLCHOLINES; PHOSPHATIDYLETHANOLAMINES;

MUS;

EID: 35649019357     PISSN: 15353893     EISSN: None     Source Type: Journal    
DOI: 10.1021/pr0700448     Document Type: Article

References (33)

1. Gu, J.; Weng, Y.; Zhang, Q. Y.; Cui, H.; Behr, M.; Wu, L.; Yang, W.; Zhang, L.; Ding, X. Liver-specific deletion of the NADPH-cytochrome P450 reductase gene: impact on plasma cholesterol homeostasis and the function and regulation of microsomal cytochrome P450 and heme oxygenase. J. Biol. Chem. 2003, 278 (28), 25895-25901.
2. Henderson, C. J.; Otto, D. M.; Carrie, D.; Magnuson, M. A.; McLaren, A. W.; Rosewell, I.; Wolf, C. R. Inactivation of the hepatic cytochrome P450 system by conditional deletion of hepatic cytochrome P450 reductase. J. Biol. Chem. 2003, 278 (15), 13480-13486.
3. Weng, Y.; DiRusso, C. C.; Reilly, A. A.; Black, P. N.; Ding, X. Hepatic gene expression changes in mouse models with liver-specific deletion or global suppression of the NADPH-cytochrome P450 reductase gene. Mechanistic implications for the regulation of microsomal cytochrome P450 and the fatty liver phenotype. J. Biol. Chem. 2005, 280 (36), 31686-31698.
4. Chiang, J. Y. Regulation of bile acid synthesis. Front. Biosci. 1998, 3, d176-d193.
5. Davis, R. A.; Miyake, J. H.; Hui, T. Y.; Spann, N. J. Regulation of cholesterol-7alpha-hydroxylase: BAREly missing a SHP. J. Lipid Res. 2002, 43 (4), 533-543.
6. Wang, X. J.; Chamberlain, M.; Vassieva, O.; Henderson, C. J.; Wolf, C. R. Relationship between hepatic phenotype and changes in gene expression in cytochrome P450 reductase (POR) null mice. Biochem. J. 2005, 388 (Pt. 3), 857-867.
7. Mutch, D. M.; Fauconnot, L.; Grigorov, M.; Fay, L. B. Putting the 'ome' in lipid metabolism. Biotechnol. Annu. Rev. 2006, 12, 67-84.
8. German, J. B.; Gillies, L. A.; Smilowitz, J. T.; Zivkovic, A. M.; Watkins, S. M. Lipidomics and lipid profiling in metabolomics. Curr. Opin. Lipidol. 2007, 18 (1), 66-71.
9. Mutch, D. M.; Crespy, V.; Clough, J.; Henderson, C. J.; Lariani, S.; Mansourian, R.; Moulin, J.; Wolf, C. R.; Williamson, G. Hepatic cytochrome P-450 reductase-null mice show reduced transcriptional response to quercetin and reveal physiological homeostasis between jejunum and liver. Am. J. Physiol.; Gastrointest. Liver Physiol. 2006, 291 (1), G63-G72.
10. Aderem, A. Systems biology: its practice and challenges. Cell 2005, 121 (4), 511-513.
11. Mansourian, R.; Mutch, D. M.; Antille, N.; Aubert, J.; Fogel, P.; Le Goff, J. M.; Moulin, J.; Petrov, A.; Rytz, A.; Voegel, J. J.; Roberts, M. A. The Global Error Assessment (GEA) model for the selection of differentially expressed genes in microarray data. Bioinformatics 2004, 20 (16), 2726-2737.
12. Watkins, S. M.; Reifsnyder, P. R.; Pan, H. J.; German, J. B.; Leiter, E. H. Lipid metabolome-wide effects of the PPARgamma agonist rosiglitazone. J. Lipid Res. 2002, 43 (11), 1809-1817.
13. Folch, J.; Lees, M.; Sloane Stanley, G. H. A simple method for the isolation and purification of total lipides from animal tissues. J. Biol. Chem. 1957, 226 (1), 497-509.
14. Watkins, S. M.; Lin, T. Y.; Davis, R. M.; Ching, J. R.; DePeters, E. J.; Halpern, G. M.; Walzern, R. L.; German, J. B. Unique phospholipid metabolism in mouse heart in response to dietary docosahexaenoic or alpha-linolenic acids. Lipids 2001, 36 (3), 247-254.
15. Seifert, M.; Scherf, M.; Epple, A.; Werner, T. Multievidence microarray mining. Trends Genet. 2005, 21 (10), 553-558.
16. Scherf, M.; Epple, A.; Werner, T. The next generation of literature analysis: integration of genomic analysis into text mining. Brief. Bioinform. 2005, 6 (3), 287-297.
17. Cartharius, K.; Frech, K.; Grote, K.; Klocke, B.; Haltmeier, M.; Klingenhoff, A.; Frisch, M.; Bayerlein, M.; Werner, T. MatInspector and beyond: promoter analysis based on transcription factor binding sites. Bioinformatics 2005, 21 (13), 2933-2942.
18. Gupta, S.; Pandak, W. M.; Hylemon, P. B. LXR alpha is the dominant regulator of CYP7A1 transcription. Biochem. Biophys. Res. Commun. 2002, 293 (1), 338-343.
19. Martinez-Jimenez, C. P.; Castell, J. V.; Gomez-Lechon, M. J.; Jover, R. Transcriptional activation of CYP2C9, CYP1A1 and CYP1A2 by HNF4{alpha} requires coactivators PGC1{alpha} and SRC1. Mol. Pharmacol. 2006, 70 (5), 1681-1692.
20. Park, S. H.; Liu, X.; Hennighausen, L.; Davey, H. W.; Waxman, D. J. Distinctive roles of STAT5a and STAT5b in sexual dimorphism of hepatic P450 gene expression. Impact of STAT5a gene disruption. J. Biol. Chem. 1999, 274 (11), 7421-7430.
21. Patsouris, D.; Reddy, J. K.; Muller, M.; Kersten, S. Peroxisome proliferator-activated receptor alpha mediates the effects of high-fat diet on hepatic gene expression. Endocrinology 2006, 147 (3), 1508-1516.
22. Tirona, R. G.; Kim, R. B. Nuclear receptors and drug disposition gene regulation. J. Pharm. Sci. 2005, 94 (6), 1169-1186.
23. Abrahamsson, A.; Gustafsson, U.; Ellis, E.; Nilsson, L. M.; Sahlin, S.; Bjorkhem, I.; Einarsson, C. Feedback regulation of bile acid synthesis in human liver: importance of HNF-4alpha for regulation of CYP7A1. Biochem. Biophys. Res. Commun. 2005, 330 (2), 395-399.
24. Crestani, M.; De Fabiani, E.; Caruso, D.; Mitro, N.; Gilardi, F.; Vigil Chacon, A. B.; Patelli, R.; Godio, C.; Galli, G. LXR (liver X receptor) and HNF-4 (hepatocyte nuclear factor-4): key regulators in reverse cholesterol transport. Biochem. Soc. Trans. 2004, 32 (Pt 1), 92-96.
25. Hihi, A. K.; Michalik, L.; Wahli, W. PPAEs: transcriptional effectors of fatty acids and their derivatives. Cell. Mol. Life Sci. 2002, 59 (5), 790-798.
26. Kalaany, N. Y.; Mangelsdorf, D. J. LXRS and FXR: the yin and yang of cholesterol and fat metabolism. Annu. Rev. Physiol. 2006, 68, 159-191.
27. Turley, S. D.; Andersen, J. M.; Dietschy, J. M. Rates of sterol synthesis and uptake in the major organs of the rat in vivo. J. Lipid Res. 1981, 22 (4), 551-569.
28. Van Eck, M.; Pennings, M.; Hoekstra, M.; Out, R.; Van Berkel, T. J. Scavenger receptor BI and ATP-binding cassette transporter A1 in reverse cholesterol transport and atherosclerosis. Curr. Opin. Lipidol. 2005, 16 (3), 307-315.
29. Plosch, T.; Kosters, A.; Groen, A. K.; Kuipers, F. The ABC of hepatic and intestinal cholesterol transport. Handb. Exp. Pharmacol. 2005, 170, 465-482.
30. Reddy, J. K.; Hashimoto, T. Peroxisomal beta-oxidation and peroxisome proliferator-activated receptor alpha: an adaptive metabolic system. Annu. Rev. Nutr. 2001, 21, 193-230.
31. Savage, D. B.; Choi, C. S.; Samuel, V. T.; Liu, Z. X.; Zhang, D.; Wang, A.; Zhang, X. M.; Cline, G. W.; Yu, X. X.; Geisler, J. G.; Bhanot, S.; Monia, B. P.; Shulman, G. I. Reversal of diet-induced hepatic steatosis and hepatic insulin resistance by antisense oligonucleotide inhibitors of acetyl-CoA carboxylases 1 and 2. J. Clin. Invest. 2006, 116 (3), 817-824.
32. Grefhorst, A.; Hoekstra, J.; Derks, T. G.; Ouwens, D. M.; Baller, J. F.; Havinga, R.; Havekes, L. M.; Romijn, J. A.; Kuipers, F. Acute hepatic steatosis in mice by blocking beta-oxidation does not reduce insulin sensitivity of very-low-density lipoprotein production. Am. J. Physiol.: Gastrointest. Liver Physiol. 2005, 289 (3), G592-G598.
33. Rinaldo, P.; Matern, D.; Bennett, M. J. Fatty acid oxidation disorders. Annu. Rev. Physiol. 2002, 64, 477-502.